CIS-MDP

Technetium Tc 99m medronate injection is a radiopharmaceutical used in imaging studies of bone integrity and function. This drug is to be given only by or under the direct supervision of a healthcare professional with specialized training in nuclear medicine.

Before doing any diagnostic test, the risks and benefits for your body should be discussed with your healthcare provider.

Inform your healthcare provider for any allergic reactions to these drugs or any other drugs, foods, dyes, preservatives, or animals. Carefully read the label of non-prescription drugs for any possible allergic reaction or contraindications.

Studies on the relationship of age to the effects of technetium Tc 99m medronate injection in the pediatric population have not been performed while safety and efficacy have not been established. There is insufficient data regarding the relationship of age to the effects of technetium Tc 99m medronate injection in geriatric patients.

Adverse effects have been reported in animal studies but studies regarding the effects in pregnant women or animals are inadequate. Infant risk is undetermined in studies of using this drug during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Drugs should not be taken together to prevent any interactions but in necessary cases inquire your healthcare provider regarding the adjustments in dosage or any other necessary precautions to prevent any unwanted side effects. Inform your healthcare professional if you are taking any other prescription or non-prescription drugs. Inform your healthcare professional if you are taking any other vaccines such as yellow fever vaccines.

Intake of specific food or using alcohol or tobacco with this vaccine is associated with an increased risk of certain side effects. Your healthcare professional can give you special instructions about the use of food, alcohol, or tobacco.

A trained healthcare professional is the only one allowed to give you this drug. This drug is given intravenously before a bone scan. Increase in fluid intake is recommended to facilitate faster excretion of this drug through the urine.

Consult with your healthcare professional to monitor the effectiveness of this drug and whether you should continue using it. Exposure to radiation is unavoidable when taking this drug and consult with your healthcare provider for any concerns. Inform your healthcare professional before having any medical test done as results of some tests may be altered by this drug.

Side effects may vary for each individual and prompt medical attention should be given if they occur.

Inform you healthcare provider if you experience unusual symptoms such as cold, clammy skin, confusion, cough, difficulty swallowing, dizziness, fast heartbeat, fast, weak pulse, hives or welts, itching, lightheadedness, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, rash, redness of the skin, shortness of breath, sweating tightness in the chest, unusual tiredness or weakness, wheezing, chills, difficult or labored breathing, fever, heart stops no breathing, no pulse or blood pressure, seizures, and unconsciousness.

Some side effects may occur that usually do not need medical attention. As your body adjusts to the medicine, the side effects will slowly disappear. Ask your healthcare professional about ways to prevent or reduce some of these side effects.

If any of the following side effects persists, or are inconvenient, or if you notice any other effects, or if you have any questions about them, consult with your health care professional. If any of the following side effects persists, or are inconvenient, or if you notice any other effects, or if you have any questions about them, consult with your health care professional.

Report any side effects to the FDA hotline at 1-800-FDA-1088.